Exhibit 10.4


 


European Biotech Acquisition Corp. 





Johannes Vermeerplein 9





1071 DV Amsterdam, Netherlands


 


March 15, 2021


 


LSP Sponsor EBAC B.V.





Johannes Vermeerplein 9





1071 DV Amsterdam, Netherlands


 


Ladies and Gentlemen:


 


This letter will confirm our agreement that, commencing on the
effective date (the “Effective Date”) of the registration statement (the “Registration Statement”)
for the initial public offering (the “IPO”) of the securities of European Biotech Acquisition Corp. (the
“Company”) and continuing until the earlier of (i) the consummation by the Company of an initial business
combination and (ii) the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date
hereinafter referred to as the “Termination Date”), LSP Sponsor EBAC B.V. (the “Sponsor”)
shall take steps directly or indirectly to make available to the Company certain office space, secretarial and administrative services
as may be required by the Company from time to time, situated at Johannes Vermeerplein 9, 1071 DV Amsterdam, Netherlands (or any
successor location). In exchange therefore, the Company shall pay the Sponsor a sum of $20,000 per month on the Effective Date
and continuing monthly thereafter until the Termination Date. The Sponsor hereby agrees that it does not have any right, title,
interest or claim of any kind (a “Claim”) in or to any monies that may be set aside in a trust account
(the “Trust Account”) that may be established upon the consummation of the IPO and hereby irrevocably
waives any Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the
Company and will not seek recourse against the Trust Account for any reason whatsoever.


 


This letter agreement constitutes the entire agreement and understanding
of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations
by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions
contemplated hereby.


 


This letter agreement may not be amended, modified or waived
as to any particular provision, except by a written instrument executed by the parties hereto.


 


The parties may not assign this letter agreement and any of
their rights, interests, or obligations hereunder without the consent of the other party.


 


This letter agreement shall be governed by, construed in accordance
with, and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of laws principles that
will apply the laws of another jurisdiction.


 


This letter agreement may be executed in one or more counterparts,
each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same agreement.
Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence
of this letter agreement.


 


[Signature Page Follows]


 




     


     


    

	 	 	 
	 	Sincerely,	 
	 	 	 
	 	EUROPEAN BIOTECH ACQUISITION CORP.
	 	 	 
	 	By:	
        /s/ Eduardo Bravo
Fernandez de Araoz

	 	Name:	 Eduardo Bravo Fernandez de Araoz
	 	Title:	 Chief Executive Officer



 




	 	 	 
	AGREED AND ACCEPTED BY:	 
	LSP SPONSOR EBAC B.V.	 
	 	 	 
	By:	
        /s/ Martijn Kleijwegt
	 

	Name:  	Martijn Kleijwegt	 
	Title:	Director	 
	 	 	 
	By:	
        /s/ Mark Wegter
	 

	Name:	Mark Wegter	 
	Title:	Director